These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23564477)
1. pH-controlled delivery of nanoparticles into tumor cells. Han L; Ma H; Guo Y; Kuang Y; He X; Jiang C Adv Healthc Mater; 2013 Nov; 2(11):1435-9. PubMed ID: 23564477 [TBL] [Abstract][Full Text] [Related]
2. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery. Huang S; Shao K; Kuang Y; Liu Y; Li J; An S; Guo Y; Ma H; He X; Jiang C Biomaterials; 2013 Jul; 34(21):5294-302. PubMed ID: 23562171 [TBL] [Abstract][Full Text] [Related]
3. Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Owen DJ; Boyd BJ; Porter CJ J Control Release; 2011 Jun; 152(2):241-8. PubMed ID: 21315119 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
5. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
6. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242 [TBL] [Abstract][Full Text] [Related]
7. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. Shen M; Huang Y; Han L; Qin J; Fang X; Wang J; Yang VC J Control Release; 2012 Aug; 161(3):884-92. PubMed ID: 22587941 [TBL] [Abstract][Full Text] [Related]
9. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819 [TBL] [Abstract][Full Text] [Related]
10. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery. Zhao Z; Meng H; Wang N; Donovan MJ; Fu T; You M; Chen Z; Zhang X; Tan W Angew Chem Int Ed Engl; 2013 Jul; 52(29):7487-91. PubMed ID: 23757374 [TBL] [Abstract][Full Text] [Related]
11. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
12. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery. Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109 [TBL] [Abstract][Full Text] [Related]
13. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Liu P; Yu H; Sun Y; Zhu M; Duan Y Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800 [TBL] [Abstract][Full Text] [Related]
14. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells. Liu CW; Lin WJ J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387 [TBL] [Abstract][Full Text] [Related]
15. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. She W; Li N; Luo K; Guo C; Wang G; Geng Y; Gu Z Biomaterials; 2013 Mar; 34(9):2252-64. PubMed ID: 23298778 [TBL] [Abstract][Full Text] [Related]
16. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848 [TBL] [Abstract][Full Text] [Related]
17. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes. Rothdiener M; Beuttler J; Messerschmidt SK; Kontermann RE Methods Mol Biol; 2010; 624():295-308. PubMed ID: 20217604 [TBL] [Abstract][Full Text] [Related]
18. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
19. A novel poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions. Yuan H; Luo K; Lai Y; Pu Y; He B; Wang G; Wu Y; Gu Z Mol Pharm; 2010 Aug; 7(4):953-62. PubMed ID: 20481567 [TBL] [Abstract][Full Text] [Related]
20. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier. Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]